The holder of this certificate has attended the course "Viral Clearance Strategies for Biopharmaceuticals and Cell & Gene Therapies". This short live online training course will enable you to understand the risk and impact of viral contamination in biopharmaceutical manufacturing. You will review the viral contamination and clearance guidance such as ICH Q5A to ensure your products comply. As well as risk prevention, you will examine in-depth viral clearance strategies and studies. Once completed, you will know what studies are required and when during CMC development to demonstrate safe viral inactivation and removal.